Childrens Allegra Allergy Suspension
Product Images NDC 41167-4244

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Childrens Allegra Allergy (NDC 41167-4244). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chattem, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ndc 41167-4244-4children’s Allegra® Allergyfexofenadine HCl Oral Suspension 30 mg/5 mL Antihistamine (Childrens Allegra Allergy Oral Suspension 01)

Ndc 41167-4244-4children’s Allegra® Allergyfexofenadine HCl Oral Suspension 30 mg/5 mL Antihistamine (Childrens Allegra Allergy Oral Suspension 01)
Label for Children's Allegra Allergy 30 mg/5 mL suspension in berry flavor by Chattem, Inc. The packaging indicates a non-drowsy 12-hour oral liquid for ages 2 years and older, for indoor/outdoor allergy relief. The 4 fl. oz. (120 mL) bottle label shows active ingredient fexofenadine HCl, uses, warnings, and dosage instructions, including use only with the enclosed dosing cup.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.